Advanced Heart Failure
26
4
6
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
3.8%
1 terminated out of 26 trials
83.3%
-3.2% vs benchmark
12%
3 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (26)
Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure
DuoCor 2 DOMINATE Study
GDF-15 and Early Outcomes After LVAD Implantation
Palliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD Support
CorWave LVAS FIH Study
Tier Palliative Care For Patients With Advanced Heart Failure or Cancer
Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD Patients
Wearables and Artificial Intelligence in Advanced Heart Failure Care
European Clinical Evaluation of the Carmat Total Artificial Heart
Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea
Hong Kong and Taiwan HM3 PMS
Cardiac Cachexia in Advanced Heart Failure
Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (SAINTS B)
Screening for Advanced Heart Failure Treatment (SEE-HF)
Ultrasound-assessed Internal Jugular Vein Distensibility in Advanced Chronic Heart Failure (US-IJVD in CHF)
Conservative Management of Left Ventricular Assist Device Candidates
Advanced Care Management in Patients With Advanced Heart Failure
PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices